{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T23:46:39Z","timestamp":1787701599505,"version":"build-2784847793"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T00:00:00Z","timestamp":1745020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T00:00:00Z","timestamp":1745020800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Chongqing Science and Technology Commission joint medical research project","award":["2023MSXM066"],"award-info":[{"award-number":["2023MSXM066"]}]},{"DOI":"10.13039\/501100005230","name":"Chongqing Natural Science Foundation","doi-asserted-by":"crossref","award":["CSTB2023NSCQ-MSX0400"],"award-info":[{"award-number":["CSTB2023NSCQ-MSX0400"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Cardiovasc Drugs"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s40256-025-00731-2","type":"journal-article","created":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T22:55:51Z","timestamp":1745016951000},"page":"633-654","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Chronotherapy for Hypertension: A Meta-Analysis and Systematic Review of RCTs"],"prefix":"10.1007","volume":"25","author":[{"given":"Hongyu","family":"Kuang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qijian","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,19]]},"reference":[{"issue":"9366","key":"731_CR1","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/S0140-6736(03)13063-2","volume":"361","author":"P Adab","year":"2003","unstructured":"Adab P, Cheng KK, Jiang CQ, Zhang WS, Lam TH. Age-specific relevance of usual blood pressure to vascular mortality. Lancet. 2003;361(9366):1389\u201390.","journal-title":"Lancet"},{"issue":"2","key":"731_CR2","doi-asserted-by":"publisher","first-page":"71","DOI":"10.5603\/KP.2019.0018","volume":"77","author":"B Williams","year":"2019","unstructured":"Williams B, Mancia G, Spiering W, et al. 2018 ESC\/ESH guidelines for the management of arterial hypertension. Kardiol Pol. 2019;77(2):71\u2013159.","journal-title":"Kardiol Pol"},{"key":"731_CR3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.smrv.2016.02.003","volume":"33","author":"MH Smolensky","year":"2017","unstructured":"Smolensky MH, Hermida RC, Portaluppi F. Circadian mechanisms of 24-hour blood pressure regulation and patterning. Sleep Med Rev. 2017;33:4\u201316.","journal-title":"Sleep Med Rev"},{"key":"731_CR4","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1161\/HYPERTENSIONAHA.120.15026","volume":"75","author":"T Unger","year":"2020","unstructured":"Unger T, Borghi C, Charchar F, et al. 2020 International society of hypertension global hypertension practice guidelines. Hypertension. 2020;75:1334\u201357.","journal-title":"Hypertension"},{"key":"731_CR5","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1056\/NEJMoa022273","volume":"348","author":"DL Clement","year":"2003","unstructured":"Clement DL, De Buyzere ML, De Bacquer DA, et al. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med. 2003;348:2407\u201315.","journal-title":"N Engl J Med"},{"key":"731_CR6","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.ijcard.2017.06.011","volume":"243","author":"M Tadic","year":"2017","unstructured":"Tadic M, Cuspidi C, Pencic-Popovic B, et al. The influence of night-time hypertension on left ventricular mechanics. Int J Cardiol. 2017;243:443\u20138.","journal-title":"Int J Cardiol"},{"issue":"4","key":"731_CR7","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.hfc.2017.05.010","volume":"13","author":"RC Hermida","year":"2017","unstructured":"Hermida RC, Ayala DE, Fern\u00e1ndez JR, et al. Bedtime blood pressure chronotherapy significantly improves hypertension management. Heart Fail Clin. 2017;13(4):759\u201373.","journal-title":"Heart Fail Clin"},{"issue":"48","key":"731_CR8","doi-asserted-by":"publisher","first-page":"4565","DOI":"10.1093\/eurheartj\/ehz754","volume":"41","author":"RC Hermida","year":"2020","unstructured":"Hermida RC, Crespo JJ, Dom\u00ednguez-Sardi\u00f1a M, et al. Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial. Eur Heart J. 2020;41(48):4565\u201376.","journal-title":"Eur Heart J"},{"issue":"3","key":"731_CR9","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1080\/08037051.2020.1747696","volume":"29","author":"R Kreutz","year":"2020","unstructured":"Kreutz R, Kjeldsen SE, Burnier M, et al. Blood pressure medication should not be routinely dosed at bedtime We must disregard the data from the HYGIA project. Blood Press. 2020;29(3):135\u20136.","journal-title":"Blood Press"},{"issue":"10361","key":"731_CR10","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/S0140-6736(22)01786-X","volume":"400","author":"IS Mackenzie","year":"2022","unstructured":"Mackenzie IS, Rogers A, Poulter NR, et al. Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trial. Lancet. 2022;400(10361):1417\u201325.","journal-title":"Lancet"},{"issue":"7","key":"731_CR11","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1161\/HYPERTENSIONAHA.122.20862","volume":"80","author":"MH Maqsood","year":"2023","unstructured":"Maqsood MH, Messerli FH, Skolnick AH, et al. Timing of antihypertensive drug therapy: a systematic review and meta-analysis of randomized clinical trials. Hypertension. 2023;80(7):1544\u201354.","journal-title":"Hypertension"},{"issue":"3","key":"731_CR12","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1161\/HYPERTENSIONAHA.122.19372","volume":"80","author":"ML Gumz","year":"2023","unstructured":"Gumz ML, Shimbo D, Abdalla M, et al. Toward precision medicine: circadian rhythm of blood pressure and chronotherapy for hypertension\u20142021 NHLBI Workshop Report. Hypertension. 2023;80(3):503\u201322.","journal-title":"Hypertension"},{"issue":"4","key":"731_CR13","first-page":"1","volume":"6","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. Epidemiol Biostat Pub Health. 2009;6(4):1\u201334.","journal-title":"Epidemiol Biostat Pub Health."},{"key":"731_CR14","doi-asserted-by":"crossref","unstructured":"WHO expert consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363(9403):157\u201363.","DOI":"10.1016\/S0140-6736(03)15268-3"},{"key":"731_CR15","doi-asserted-by":"crossref","unstructured":"Deeks JJ, Higgins JPT, Altman DG, et al. on behalf of the Cochrane Statistical Methods Group. Chapter 10: Analysing data and undertaking meta-analyses.\u00a0In: Higgins J, Thomas, Chandler J, et al. (eds). Cochrane Handbook for Systematic Reviews of Interventions. Version 6.5. 2019; The Cochrane Collaboration. https:\/\/training.cochrane.org\/handbook\/current\/chapter-10","DOI":"10.1002\/9781119536604.ch10"},{"key":"731_CR16","doi-asserted-by":"crossref","unstructured":"Boutron I, Page MJ, Higgins JPT, et al. on behalf of the Cochrane Bias Methods Group. Chapter 7: Considering bias and conflicts of interest among the included studies.\u00a0In: Higgins J, Thomas, Chandler J, et al. (eds). Cochrane Handbook for Systematic Reviews of Interventions. Version 6.5. 2019; The Cochrane Collaboration. https:\/\/training.cochrane.org\/handbook\/current\/chapter-07","DOI":"10.1002\/9781119536604.ch7"},{"key":"731_CR17","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1016\/0002-8703(92)91064-8","volume":"123","author":"P Palatini","year":"1992","unstructured":"Palatini P. Can an angiotensin-converting enzyme inhibitor with a short half-life effectively lower blood pressure for 24 hours? Am Heart J. 1992;123:1421\u20135.","journal-title":"Am Heart J"},{"key":"731_CR18","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/clpt.1993.129","volume":"54","author":"K Witte","year":"1993","unstructured":"Witte K, Weisser K, Neubeck M, et al. Cardiovascular effects, pharmacokinetics, and converting enzyme inhibition of enalapril after morning versus evening administration. Clin Pharmacol Ther. 1993;54:177\u201386.","journal-title":"Clin Pharmacol Ther"},{"key":"731_CR19","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1097\/00004872-199312000-00013","volume":"11","author":"T Mengden","year":"1993","unstructured":"Mengden T, Binswanger B, Sp\u00fchler T, et al. The use of self-measured blood pressure determinations in assessing dynamics of drug compliance in a study with amlodipine once a day, morning versus evening. J Hypertens. 1993;11:1403\u201311.","journal-title":"J Hypertens"},{"key":"731_CR20","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/j.1365-2125.1993.tb05670.x","volume":"35","author":"R Fogari","year":"1993","unstructured":"Fogari R, Malacco E, Tettamanti F, et al. Evening vs morning isradipine sustained release in essential hypertension: a double-blind study with 24 h ambulatory monitoring. Br J Clin Pharmacol. 1993;35:51\u20134.","journal-title":"Br J Clin Pharmacol"},{"issue":"12","key":"731_CR21","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/0011-393X(95)85074-0","volume":"56","author":"DP Myburgh","year":"1995","unstructured":"Myburgh DP, Verho M, Botes JH, Erasmus TP, Luus HG. 24-hour blood pressure control with ramipril: comparison of once-daily morning and evening administration. Curr Ther Res Clin Exp. 1995;56(12):1298\u2013306.","journal-title":"Curr Ther Res Clin Exp"},{"key":"731_CR22","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/00004872-199715020-00012","volume":"15","author":"T Morgan","year":"1997","unstructured":"Morgan T, Anderson A, Jones E. The effect on 24 h blood pressure control of an angiotensin converting enzyme inhibitor (perindopril) administered in the morning or at night. J Hypertens. 1997;15:205\u201311.","journal-title":"J Hypertens"},{"key":"731_CR23","first-page":"17","volume":"3","author":"G Nold","year":"1998","unstructured":"Nold G, Strobel G, Lemmer B. Morning versus evening amlodipine treatment: effect on circadian blood pressure profile in essential hypertensive patients. Blood Press Monit. 1998;3:17\u201325.","journal-title":"Blood Press Monit"},{"key":"731_CR24","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1097\/00004872-199816030-00016","volume":"16","author":"A Pech\u00e8re-Bertschi","year":"1998","unstructured":"Pech\u00e8re-Bertschi A, Nussberger J, Decosterd L, et al. Renal response to the angiotensin II receptor subtype 1 antagonist irbesartan versus enalapril in hypertensive patients. J Hypertens. 1998;16:385\u201393.","journal-title":"J Hypertens"},{"key":"731_CR25","first-page":"269","volume":"3","author":"C Macchiarulo","year":"1999","unstructured":"Macchiarulo C, Pieri R, Mitolo DC, et al. Management of antihypertensive treatment with Lisinopril: a chronotherapeutic approach. Eur Rev Med Pharmacol Sci. 1999;3:269\u201375.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"731_CR26","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/S0002-9149(97)00935-1","volume":"81","author":"WB White","year":"1998","unstructured":"White WB, Black HR, Weber MA, et al. Comparison of effects of controlled onset extended release verapamil at bedtime and nifedipine gastrointestinal therapeutic system on arising on early morning blood pressure, heart rate, and the heart rate-blood pressure product. Am J Cardiol. 1998;81:424\u201331.","journal-title":"Am J Cardiol"},{"key":"731_CR27","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1081\/CBI-100101044","volume":"17","author":"I Kohno","year":"2000","unstructured":"Kohno I, Ijiri H, Takusagawa M, et al. Effect of imidapril in dipper and nondipper hypertensive patients: comparison between morning and evening administration. Chronobiol Int. 2000;17:209\u201319.","journal-title":"Chronobiol Int"},{"key":"731_CR28","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1023\/A:1027347723347","volume":"17","author":"YG Qiu","year":"2003","unstructured":"Qiu YG, Chen JZ, Zhu JH, et al. Differential effects of morning or evening dosing of amlodipine on circadian blood pressure and heart rate. Cardiovasc Drugs Ther. 2003;17:335\u201341.","journal-title":"Cardiovasc Drugs Ther"},{"key":"731_CR29","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1161\/01.HYP.0000084855.32823.DA","volume":"42","author":"RC Hermida","year":"2003","unstructured":"Hermida RC, Calvo C, Ayala DE, et al. Administration time-dependent effects of valsartan on ambulatory blood pressure in hypertensive subjects. Hypertension. 2003;42:283\u201390.","journal-title":"Hypertension"},{"key":"731_CR30","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0895-7061(02)03153-9","volume":"16","author":"SP Glasser","year":"2003","unstructured":"Glasser SP, Neutel JM, Gana TJ, et al. Efficacy and safety of a once daily graded-release diltiazem formulation in essential hypertension. Am J Hypertens. 2003;16:51\u20138.","journal-title":"Am J Hypertens"},{"key":"731_CR31","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1097\/00005344-200401000-00011","volume":"43","author":"Y Kitahara","year":"2004","unstructured":"Kitahara Y, Saito F, Akao M, et al. Effect of morning and bedtime dosing with cilnidipine on blood pressure, heart rate, and sympathetic nervous activity in essential hypertensive patients. J Cardiovasc Pharmacol. 2004;43:68\u201373.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"1","key":"731_CR32","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1291\/hypres.27.15","volume":"27","author":"T Kuroda","year":"2004","unstructured":"Kuroda T, Kario K, Hoshide S, et al. Effects of bedtime vs. morning administration of the long-acting lipophilic angiotensin-converting enzyme inhibitor trandolapril on morning blood pressure in hypertensive patients. Hypertens Res. 2004;27(1):15\u201320.","journal-title":"Hypertens Res"},{"issue":"2","key":"731_CR33","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1081\/CBI-120037772","volume":"21","author":"RC Hermida","year":"2004","unstructured":"Hermida RC, Calvo C, Ayala DE, et al. Administration-time-dependent effects of doxazosin GITS on ambulatory blood pressure of hypertensive subjects. Chronobiol Int. 2004;21(2):277\u201396.","journal-title":"Chronobiol Int"},{"issue":"7","key":"731_CR34","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/j.1524-6175.2005.04304.x","volume":"7","author":"JM Neutel","year":"2005","unstructured":"Neutel JM, Rotenberg K. Comparison of a chronotherapeutically administered \u03b2 blocker vs a traditionally administered \u03b2 blocker in patients with hypertension. J Clin Hypertens (Greenwich). 2005;7(7):395\u2013400.","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"731_CR35","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1097\/01.hjh.0000182522.21569.c5","volume":"23","author":"RC Hermida","year":"2005","unstructured":"Hermida RC, Calvo C, Ayala DE, et al. Treatment of non-dipper hypertension with bedtime administration of valsartan. J Hypertens. 2005;23:1913\u201322.","journal-title":"J Hypertens"},{"key":"731_CR36","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1080\/07420520500180488","volume":"22","author":"RC Hermida","year":"2005","unstructured":"Hermida RC, Calvo C, Ayala DE, et al. Administration time-dependent effects of valsartan on ambulatory blood pressure in elderly hypertensive subjects. Chronobiol Int. 2005;22:755\u201376.","journal-title":"Chronobiol Int"},{"key":"731_CR37","unstructured":"Koga H, Hayashi J, Yamamoto M, et al. Prevention of morning surge of hypertension by the evening administration of carvedilol. Japan Medical Association Journal. 2005;48(8):398-403."},{"key":"731_CR38","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1157\/13095521","volume":"127","author":"C Calvo","year":"2006","unstructured":"Calvo C, Hermida RC, Ayala DE, et al. Chronotherapy with torasemide in hypertensive patients: increased efficacy and therapeutic coverage with bedtime administration. Med Clin (Barc). 2006;127:721\u20139.","journal-title":"Med Clin (Barc)"},{"key":"731_CR39","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1080\/07420520600969277","volume":"24","author":"MH Smolensky","year":"2007","unstructured":"Smolensky MH, Hermida RC, Portaluppi F. Comparison of the efficacy of morning versus evening administration of olmesartan in uncomplicated essential hypertension. Chronobiol Int. 2007;24:171\u201381.","journal-title":"Chronobiol Int"},{"key":"731_CR40","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1161\/HYPERTENSIONAHA.107.094235","volume":"50","author":"RC Hermida","year":"2007","unstructured":"Hermida RC, Ayala DE, Fern\u00e1ndez JR, et al. Comparison of the efficacy of morning versus evening administration of telmisartan in essential hypertension. Hypertension. 2007;50:715\u201322.","journal-title":"Hypertension"},{"issue":"3","key":"731_CR41","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1080\/07420520701420683","volume":"24","author":"RC Hermida","year":"2007","unstructured":"Hermida RC, Calvo C, Ayala DE, et al. Dose and administration time-dependent effects of nifedipine gits on ambulatory blood pressure in hypertensive subjects. Chronobiol Int. 2007;24(3):471.","journal-title":"Chronobiol Int"},{"issue":"6","key":"731_CR42","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1080\/07420520802544589","volume":"25","author":"RC Hermida","year":"2008","unstructured":"Hermida RC, Ayala DE, Artemio M, et al. Comparison of the effects on ambulatory blood pressure of awakening versus bedtime administration of torasemide in essential hypertension. Chronobiol Int. 2008;25(6):950\u201370.","journal-title":"Chronobiol Int"},{"issue":"8","key":"731_CR43","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1038\/ajh.2008.216","volume":"21","author":"RC Hermida","year":"2008","unstructured":"Hermida RC, Ayala DE, Mojon A, et al. Chronotherapy with nifedipine GITS in hypertensive patients: improved efficacy and safety with bedtime dosing. Am J Hypertens. 2008;21(8):948\u201354.","journal-title":"Am J Hypertens"},{"issue":"1","key":"731_CR44","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1161\/HYPERTENSIONAHA.109.130203","volume":"54","author":"RC Hermida","year":"2009","unstructured":"Hermida RC, Ayala DE. Chronotherapy with the angiotensin-converting enzyme inhibitor ramipril in essential hypertension: improved blood pressure control with bedtime dosing. Hypertension. 2009;54(1):40\u20136.","journal-title":"Hypertension"},{"issue":"3","key":"731_CR45","doi-asserted-by":"publisher","first-page":"560","DOI":"10.3109\/07420528.2010.485411","volume":"27","author":"RC Hermida","year":"2010","unstructured":"Hermida RC, Ayala DE, Fontao MJ, et al. Administration-time-dependent effects of spirapril on ambulatory blood pressure in uncomplicated essential hypertension. Chronobiol Int. 2010;27(3):560\u201374.","journal-title":"Chronobiol Int"},{"issue":"1","key":"731_CR46","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1080\/07420520802548135","volume":"26","author":"RC Hermida","year":"2009","unstructured":"Hermida RC, Ayala DE, Chay\u00e1n L, et al. Administration-time-dependent effects of olmesartan on the ambulatory blood pressure of essential hypertension patients. Chronobiol Int. 2009;26(1):61\u201379.","journal-title":"Chronobiol Int"},{"issue":"4","key":"731_CR47","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1097\/MBP.0b013e32832e0d80","volume":"14","author":"RC Hermida","year":"2009","unstructured":"Hermida RC, Ayala DE, Artemio M, et al. Reduction of morning blood pressure surge after treatment with nifedipine GITS at bedtime, but not upon awakening, in essential hypertension. Blood Press Monit. 2009;14(4):152\u20139.","journal-title":"Blood Press Monit"},{"key":"731_CR48","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1111\/j.1751-7176.2009.00152.x","volume":"11","author":"S Tof\u00e9 Povedano","year":"2009","unstructured":"Tof\u00e9 Povedano S, Garc\u00eda De La Villa B. 24-hour and nighttime blood pressures in type 2 diabetic hypertensive patients following morning or evening administration of olmesartan. J Clin Hypertens (Greenwich). 2009;11:426\u201331.","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"6","key":"731_CR49","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.3109\/07420528.2010.489167","volume":"27","author":"RC Hermida","year":"2010","unstructured":"Hermida RC, Ayala DE, Fontao MJ, et al. Chronotherapy with valsartan\/amlodipine fixed combination improved blood pressure control of essential hypertension with bedtime dosing. Chronobil Int. 2010;27(6):1287\u2013303.","journal-title":"Chronobil Int."},{"issue":"7","key":"731_CR50","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1097\/HJH.0b013e3283395267","volume":"28","author":"K Kario","year":"2010","unstructured":"Kario K, Hoshide S, Shimizu M, et al. Effect of dosing time of angiotensin II receptor blockade titrated by self-measured blood pressure recordings on cardiorenal protection in hypertensives: the Japan Morning Surge-Target Organ Protection (J-TOP) study. J Hypertens. 2010;28(7):1574\u201383.","journal-title":"J Hypertens"},{"issue":"3","key":"731_CR51","doi-asserted-by":"publisher","first-page":"309","DOI":"10.2143\/AC.65.3.2050347","volume":"65","author":"YY Meng","year":"2010","unstructured":"Meng YY, Zhang ZX, Liang XG, et al. Effects of combination therapy with amlodipine and fosinopril at different times on blood pressure and circadian blood pressure pattern in patients with essential hypertension. Acta Cardiol. 2010;65(3):309\u201314.","journal-title":"Acta Cardiol"},{"issue":"1","key":"731_CR52","doi-asserted-by":"publisher","first-page":"6","DOI":"10.20996\/1819-6446-2011-7-1-6-18","volume":"7","author":"VM Gorbunov","year":"2016","unstructured":"Gorbunov VM, Fedorova EY, Deev AD, et al. Influence of chronotherapy with different antihypertensive drugs on circadian blood pressure pattern. Ration Pharmacother Cardiol. 2016;7(1):6\u201318.","journal-title":"Ration Pharmacother Cardiol."},{"issue":"2","key":"731_CR53","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1097\/MBP.0b013e328344c6db","volume":"16","author":"R Asmar","year":"2011","unstructured":"Asmar R, Gosse P, Quer\u00e9 S, et al. Efficacy of morning and evening dosing of amlodipine\/valsartan combination in hypertensive patients uncontrolled by 5 mg of amlodipine. Blood Press Monit. 2011;16(2):80\u20136.","journal-title":"Blood Press Monit"},{"issue":"7","key":"731_CR54","doi-asserted-by":"publisher","first-page":"601","DOI":"10.3109\/07420528.2011.589935","volume":"28","author":"RC Hermida","year":"2011","unstructured":"Hermida RC, Ayala DE, Artemio M, et al. Chronotherapy with valsartan\/hydrochlorothiazide dosing. Chronobiol Int. 2011;28(7):601\u201310.","journal-title":"Chronobiol Int"},{"issue":"6","key":"731_CR55","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/hr.2011.36","volume":"34","author":"J Zeng","year":"2011","unstructured":"Zeng J, Jia M, Ran H, et al. Fixed-combination of amlodipine and diuretic chronotherapy in the treatment of essential hypertension: improved blood pressure control with bedtime dosing-a multicenter, open-label randomized study. Hypertens Res. 2011;34(6):767\u201372.","journal-title":"Hypertens Res"},{"issue":"1","key":"731_CR56","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jash.2011.09.001","volume":"6","author":"MC Acelajado","year":"2012","unstructured":"Acelajado MC, Pisoni R, Dudenbostel T, et al. Both morning and evening dosing of nebivolol reduces trough mean blood pressure surge in hypertensive patients. J Am Soc Hypertens. 2012;6(1):66\u201372.","journal-title":"J Am Soc Hypertens"},{"key":"731_CR57","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1093\/ndt\/gfr557","volume":"27","author":"J Almirall","year":"2012","unstructured":"Almirall J, Comas L, Martinez-Ocana JC, et al. Effects of chronotherapy on blood pressure control in non-dipper patients with refractory hypertension. Nephrol Dial Transplant. 2012;27:1855\u20139.","journal-title":"Nephrol Dial Transplant"},{"key":"731_CR58","doi-asserted-by":"publisher","first-page":"340","DOI":"10.3109\/07420528.2012.701455","volume":"30","author":"DE Ayala","year":"2013","unstructured":"Ayala DE, Hermida RC, Moj\u00f3n A, et al. Cardiovascular risk of resistant hypertension: dependence on treatment-time regimen of blood pressure-lowering medications. Chronobiol Int. 2013;30:340\u201352.","journal-title":"Chronobiol Int"},{"key":"731_CR59","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/hr.2012.142","volume":"36","author":"H Mori","year":"2013","unstructured":"Mori H, Yamamoto H, Ukai H, et al. Comparison of effects of angiotensin II receptor blocker on morning home blood pressure and cardiorenal protection between morning administration and evening administration in hypertensive patients: the COMPATIBLE study. Hypertens Res. 2013;36:202\u20137.","journal-title":"Hypertens Res"},{"key":"731_CR60","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1097\/MBP.0b013e3283624aed","volume":"18","author":"R Farah","year":"2013","unstructured":"Farah R, Makhoul N, Arraf Z, et al. Switching therapy to bedtime for uncontrolled hypertension with a nondipping pattern: a prospective randomized-controlled study. Blood Press Monit. 2013;18:227\u201331.","journal-title":"Blood Press Monit"},{"key":"731_CR61","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/hr.2013.10","volume":"36","author":"M Ohishi","year":"2013","unstructured":"Ohishi M, Kawai T, Hayashi N, et al. Effect of tablets with a combination of telmisartan and amlodipine on patients with hypertension: the Cotalo study. Hypertens Res. 2013;36:620\u20136.","journal-title":"Hypertens Res"},{"issue":"6","key":"731_CR62","first-page":"484","volume":"41","author":"GC Peng","year":"2013","unstructured":"Peng GC, Wang YF, Xiao Y, et al. Blood pressure lowering efficacy of telmisartan and amlodipine taking on the morning or at bedtime. Chin J Cardiol. 2013;41(6):484\u20137.","journal-title":"Chin J Cardiol."},{"key":"731_CR63","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1161\/HYPERTENSIONAHA.114.03958","volume":"64","author":"NB Rossen","year":"2014","unstructured":"Rossen NB, Knudsen ST, Fleischer J, et al. Targeting nocturnal hypertension in type 2 diabetes mellitus. Hypertension. 2014;64:1080\u20137.","journal-title":"Hypertension"},{"issue":"2","key":"731_CR64","first-page":"211","volume":"26","author":"Z Zhang","year":"2014","unstructured":"Zhang Z, Liu M, Che M, et al. Influence of different time treatment regimen of antihypertensive medication on morning blood pressure surge and blood pressure variability in hypertension patients. Med J West China. 2014;26(2):211\u2013316.","journal-title":"Med J West China."},{"issue":"2","key":"731_CR65","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1097\/HJH.0000000000000397","volume":"33","author":"DH Zappe","year":"2015","unstructured":"Zappe DH, Crikelair N, Kandra A, et al. Time of administration important? Morning versus evening dosing of valsartan. J Hypertens. 2015;33(2):385\u201392.","journal-title":"J Hypertens"},{"issue":"1","key":"731_CR66","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jphs.2014.09.004","volume":"127","author":"K Ushijima","year":"2015","unstructured":"Ushijima K, Nakashima H, Shiga T, et al. Different chronotherapeutic effects of valsartan and olmesartan in non-dipper hypertensive patients during valsartan treatment at morning. J Pharmacol Sci. 2015;127(1):62\u20138.","journal-title":"J Pharmacol Sci"},{"issue":"5","key":"731_CR67","first-page":"492","volume":"17","author":"Z Qiao","year":"2015","unstructured":"Qiao Z, Zhuang R, Li Y. Effect of candesartan taken before going to bed on morning blood pressure surge and mALB in hypertensive patients. Chin J Geriatric Heart Brain Vessel Dis. 2015;17(5):492\u20134.","journal-title":"Chin J Geriatric Heart Brain Vessel Dis."},{"issue":"13","key":"731_CR68","first-page":"1794","volume":"31","author":"L Zhao","year":"2015","unstructured":"Zhao L, Liu S, Gan B. Effect of different time of taking medicine on blood pressure of elderly patients with non-dipper hypertension. Occup Health. 2015;31(13):1794\u20131780.","journal-title":"Occup Health"},{"issue":"10","key":"731_CR69","first-page":"19156","volume":"8","author":"W Huangfu","year":"2015","unstructured":"Huangfu W, Duan P, Xiang D, et al. Administration time-dependent effects of combination therapy on ambulatory blood pressure in hypertensive subjects. Int J Clin Exp Med. 2015;8(10):19156\u201361.","journal-title":"Int J Clin Exp Med"},{"issue":"10","key":"731_CR70","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1111\/jch.12814","volume":"18","author":"K Kario","year":"2016","unstructured":"Kario K, Hoshide S, Uchiyama K, et al. Dose timing of an angiotensin II receptor blocker\/calcium channel blocker combination in hypertensive patients with paroxysmal atrial fibrillation. J Clin Hypertens (Greenwich). 2016;18(10):1036\u201344.","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"S1","key":"731_CR71","first-page":"21","volume":"24","author":"H Li","year":"2016","unstructured":"Li H, Wang D. Intervention effect of enalapril folic acid tables on H-type hypertensive patients with morning peak blood pressure. Pract J Cardiac Cereb Pneumal Vasc Dis. 2016;24(S1):21\u20133.","journal-title":"Pract J Cardiac Cereb Pneumal Vasc Dis."},{"key":"731_CR72","doi-asserted-by":"publisher","first-page":"37","DOI":"10.26442\/SG29137","volume":"13","author":"AV Aksenova","year":"2016","unstructured":"Aksenova AV, Elfimova EM, Litvin AY, et al. Chronotherapy\u2019s opportunities of a fixed combination of perindopril 10 mg\/ indapamide 2.5 mg in patients with a lack of night reduction in blood pressure. Syst Hypertens. 2016;13:37\u201345.","journal-title":"Syst Hypertens."},{"key":"731_CR73","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1161\/HYPERTENSIONAHA.118.11101","volume":"72","author":"NR Poulter","year":"2018","unstructured":"Poulter NR, Savopoulos C, Anjum A, et al. Randomized crossover trial of the impact of morning or evening dosing of antihypertensive agents on 24-hour ambulatory blood pressure. Hypertension. 2018;72:870\u20133.","journal-title":"Hypertension"},{"key":"731_CR74","first-page":"63A","volume":"18","author":"RC Hermida","year":"2005","unstructured":"Hermida RC, Calvo C, Ayala DE, et al. Administration time-dependent effects of nebivolol on ambulatory blood pressure in patients with essential hypertension. Am J Hypertens. 2005;18:63A-63A.","journal-title":"Am J Hypertens"},{"key":"731_CR75","doi-asserted-by":"publisher","DOI":"10.15829\/1560-4071-2018-4-56-66","author":"VVF Skibitsky","year":"2018","unstructured":"Skibitsky VVF, Opolskaya SV. Comprison of influence of various regimens of drug intake on 24 hour blood pressure, central aortic pressure and vascular wall stiffness in systemic hypertension patients with ischemic stroke. Russ J Cardiol. 2018. https:\/\/doi.org\/10.15829\/1560-4071-2018-4-56-66.","journal-title":"Russ J Cardiol"},{"key":"731_CR76","first-page":"721","volume":"70","author":"HO Ovchan","year":"2017","unstructured":"Ovchan HO, Khomenko VM, Andrushko II, et al. Experience and comparison of antihypertensive effect of ace inhibitor spirapril and calcium antagonist amlodipinein standard and chronotherapeutic prescription mode. Wiad Lek. 2017;70:721\u20134.","journal-title":"Wiad Lek"},{"issue":"5","key":"731_CR77","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1161\/HYPERTENSIONAHA.121.14519","volume":"78","author":"HM Costello","year":"2021","unstructured":"Costello HM, Gumz ML. Circadian rhythm, clock genes, and hypertension: recent advances in hypertension. Hypertension. 2021;78(5):1185\u201396.","journal-title":"Hypertension"},{"key":"731_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2021.101454","volume":"59","author":"RC Hermida","year":"2021","unstructured":"Hermida RC, Mojon A, Hermida-Ayala RC, et al. Extent of asleep blood pressure reduction by hypertension medications is ingestion-time dependent: systematic review and meta-analysis of published human trials. Sleep Med Rev. 2021;59: 101454.","journal-title":"Sleep Med Rev"},{"issue":"9366","key":"731_CR79","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/S0140-6736(03)13063-2","volume":"361","author":"P Adab","year":"2003","unstructured":"Adab P, Cheng K, Jiang C, et al. Age-specific relevance of usual blood pressure to vascular mortality. Lancet. 2003;361(9366):1389\u201390.","journal-title":"Lancet"},{"issue":"18","key":"731_CR80","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1016\/j.jacc.2021.03.291","volume":"7","author":"V Parcha","year":"2021","unstructured":"Parcha V, Patel N, Gutierrez OM, et al. Chronobiology of natriuretic peptides and blood pressure in lean and obese individuals. J Am Coll Cardiol. 2021;7(18):2291\u2013303.","journal-title":"J Am Coll Cardiol"},{"key":"731_CR81","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1161\/HYPERTENSIONAHA.120.14790","volume":"76","author":"T Fujiwara","year":"2020","unstructured":"Fujiwara T, Hoshide S, Kanegae H, Kario K. Cardiovascular event risks associated with masked nocturnal hypertension defined by home blood pressure monitoring in the J-HOP nocturnal blood pressure study. Hypertension. 2020;76:259\u201366.","journal-title":"Hypertension"},{"key":"731_CR82","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1161\/HYPERTENSIONAHA.118.12740","volume":"73","author":"K Kario","year":"2019","unstructured":"Kario K, Kanegae H, Tomitani N, et al. Nighttime blood pressure measured by home blood pressure monitoring as an independent predictor of cardiovascular events in general practice. Hypertension. 2019;73:1240\u20138.","journal-title":"Hypertension"},{"key":"731_CR83","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1161\/01.HYP.0000152079.04553.2c","volume":"45","author":"M Kikuya","year":"2005","unstructured":"Kikuya M, Ohkubo T, Asayama K, et al. Ambulatory blood pressure and 10-year risk of cardiovascular and noncardiovascular mortality: the Ohasama study. Hypertension. 2005;45:240\u20135.","journal-title":"Hypertension"},{"key":"731_CR84","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1161\/HYPERTENSIONAHA.119.14344","volume":"76","author":"GG Mokwatsi","year":"2020","unstructured":"Mokwatsi GG, Hoshide S, Kanegae H, et al. Direct comparison of home versus ambulatory defined nocturnal hypertension for predicting cardiovascular events: the Japan morning surge-home blood pressure (J-HOP) study. Hypertension. 2020;76:554\u201361.","journal-title":"Hypertension"}],"container-title":["American Journal of Cardiovascular Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-025-00731-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40256-025-00731-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-025-00731-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T14:06:55Z","timestamp":1757167615000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40256-025-00731-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,19]]},"references-count":84,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["731"],"URL":"https:\/\/doi.org\/10.1007\/s40256-025-00731-2","relation":{},"ISSN":["1175-3277","1179-187X"],"issn-type":[{"value":"1175-3277","type":"print"},{"value":"1179-187X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,19]]},"assertion":[{"value":"5 March 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interests"}},{"value":"This study was approved by Chongqing Science and Technology Commission joint medical research project (2023MSXM066) and Chongqing Natural Science Foundation (CSTB2023 NSCQ-MSX0400).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Hongyu Kuang and Qiang Li contributed to the literature search and study design. Qiang Li and Hongyu Kuang conducted the meta-analyses and participated in the drafting of the article. Hongyu Kuang, Huaan Du, and Qijian Yi revised the manuscript.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}},{"value":"Data and materials are available by contacting the corresponding author.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Materials"}}]}}